Skip to main content

DINAMICA DEL GENOMA Y TRANSICIONES DEL DESARROLLO EN EMBRIONES Y CELULAS MADRE

PID2023-151742NB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The JAK2 46/1 haplotype influences PD-L1 expression

  • Carreño-Tarragona, Gonzalo
  • Tiana, María
  • Rouco, Raquel
  • Leivas, Alejandra
  • Victorino, Jesús
  • García-Vicente, Roberto
  • Chase, Andrew J.
  • Maidana, Andrea
  • Tapper, William J.
  • Ayala, Rosa
  • Cross, Nicholas C. P.
  • Martínez-López, Joaquín
  • Manzanares, Miguel
Although described more than a decade ago, the mechanism by which the JAK2 46/1 haplotype increases the risk of developing JAK2-mutated myeloproliferative neoplasms (MPNs) remains unexplained. Inflammation and immunity are linked to MPN development and thus could be relevant to the mechanism by which 46/1 mediates its effect. Here, we show that programmed death-1 receptor ligand (PD-L1) expression is elevated in 46/1 haplotype, both in healthy carriers and in CD34 cells from patients with MPN. Using circular chromosome conformation capture, we observed that PD-L1 and the neighboring PD-L2 loci physically interact with JAK2 in a manner that differs between 46/1 and nonrisk haplotypes. CRISPR/Cas9 genome editing identified a region within JAK2 intron 2 that influences both JAK2 and PD-L1 expression. We suggest that increased PD-L1 expression may be relevant to the mechanism by which 46/1 leads to an increased inherited risk of developing MPN., This study was funded by the Asociacion Española Contra el Cáncer (AECC) Ideas Semilla AECC 2017 grants PID2020-115755GB-I00 and PID2023-151742NB-I00 (funded by Ministerio de Ciencia, Innovacion y Universidades /Agencia Estatal de Investigación [AEI]/10.13039/ 501100011033); by the Subdireccion General de Investigación Sanitaria ´ (Instituto de Salud Carlos III, Spain) grant PI19/01518; by the Cancer Research Innovation in Science (CRIS) Against Cancer Foundation grant 2018/001; and by the Instituto de Investigacion Hospital 12 de Octubre (IMAS12). CBM is supported by an institutional grant from the Fundacion Ramón Areces and Severo Ochoa Center of Excellence (grant CEX2021-001154-S, funded by Ministerio de Ciencia e Innovacion /AEI/10.13039/501100011033).